Literature DB >> 9032354

Disassociation between the in vitro and in vivo effects of nitric oxide on a neurotropic murine coronavirus.

T E Lane1, A D Paoletti, M J Buchmeier.   

Abstract

Intranasal inoculation of the neuroattenuated OBLV60 strain of mouse hepatitis virus results in infection of mitral neurons in the olfactory bulb, followed by spread along olfactory and limbic pathways to the brain. Immunocompetent BALB/c mice were able to clear virus by 11 days postinfection (p.i.). Gamma interferon (IFN-gamma) may play a role in clearance of OBLV60 from infected immunocompetent BALB/c mice through a nonlytic mechanism. Among the variety of immunomodulatory activities of IFN-gamma is the induction of expression of inducible nitric oxide synthase (iNOS), an enzyme responsible for the production of nitric oxide (NO). Studies were undertaken to investigate the role of IFN-gamma and NO in host defense and clearance of OBLV60 from the central nervous system (CNS). Exposure of OBLV60-infected OBL21a cells, a mouse neuronal cell line, to the NO-generating compound S-nitroso-L-acetyl penicillamine resulted in a significant decrease in viral replication, indicating that NO interfered with viral replication. Furthermore, infection of IFN-gamma knockout (GKO) mice and athymic nude mice with OBLV60 resulted in low-level expression of iNOS mRNA and protein in the brains compared to that of OBLV60-infected BALB/c mice. Nude mice were unable to clear virus and eventually died between days 11 and 14 p.i. (B. D. Pearce, M. V. Hobbs, T. S. McGraw, and M. J. Buchmeier, J. Virol. 68:5483-5495, 1994); however, GKO mice survived infection and cleared virus by day 18 p.i. These data suggest that IFN-gamma production in the olfactory bulb contributed to but may not be essential for clearance of OBLV60 from the brain. In addition, treatment of OBLV60-infected BALB/c mice with aminoguanidine, a selective inhibitor of iNOS activity, did not result in any increase in mortality, and the mice cleared the virus by 11 days p.i. These data suggest that although NO was able to block replication of virus in vitro, expression of iNOS with NO release in vivo did not appear to be the determinant factor in clearance of OBLV60 from CNS neurons.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9032354      PMCID: PMC191327     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme.

Authors:  C J Lowenstein; C S Glatt; D S Bredt; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

2.  Selective inhibition of the inducible nitric oxide synthase by aminoguanidine.

Authors:  T P Misko; W M Moore; T P Kasten; G A Nickols; J A Corbett; R G Tilton; M L McDaniel; J R Williamson; M G Currie
Journal:  Eur J Pharmacol       Date:  1993-03-16       Impact factor: 4.432

3.  A case for cytokines as effector molecules in the resolution of virus infection.

Authors:  A J Ramsay; J Ruby; I A Ramshaw
Journal:  Immunol Today       Date:  1993-04

4.  In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases.

Authors:  H Koprowski; Y M Zheng; E Heber-Katz; N Fraser; L Rorke; Z F Fu; C Hanlon; B Dietzschold
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

5.  Inhibition of nitric oxide synthesis increases mortality in Sindbis virus encephalitis.

Authors:  P C Tucker; D E Griffin; S Choi; N Bui; S Wesselingh
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

6.  Evidence for antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication.

Authors:  K D Croen
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

7.  Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction.

Authors:  J A Corbett; R G Tilton; K Chang; K S Hasan; Y Ido; J L Wang; M A Sweetland; J R Lancaster; J R Williamson; M L McDaniel
Journal:  Diabetes       Date:  1992-04       Impact factor: 9.461

8.  Induction of nitric oxide synthase in glial cells.

Authors:  M L Simmons; S Murphy
Journal:  J Neurochem       Date:  1992-09       Impact factor: 5.372

9.  Multiple defects of immune cell function in mice with disrupted interferon-gamma genes.

Authors:  D K Dalton; S Pitts-Meek; S Keshav; I S Figari; A Bradley; T A Stewart
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

10.  The role of gamma interferon in infection of susceptible mice with murine coronavirus, MHV-JHM.

Authors:  A L Smith; S W Barthold; M S de Souza; K Bottomly
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

View more
  48 in total

Review 1.  Does nitric oxide play a critical role in viral infections?

Authors:  C S Reiss; T Komatsu
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

2.  A central role for CD4(+) T cells and RANTES in virus-induced central nervous system inflammation and demyelination.

Authors:  T E Lane; M T Liu; B P Chen; V C Asensio; R M Samawi; A D Paoletti; I L Campbell; S L Kunkel; H S Fox; M J Buchmeier
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  Yellow fever virus encephalitis: properties of the brain-associated T-cell response during virus clearance in normal and gamma interferon-deficient mice and requirement for CD4+ lymphocytes.

Authors:  T Liu; T J Chambers
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

4.  Coronavirus-induced demyelination occurs in the absence of inducible nitric oxide synthase.

Authors:  G F Wu; L Pewe; S Perlman
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

5.  Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus.

Authors:  Sara Akerström; Mehrdad Mousavi-Jazi; Jonas Klingström; Mikael Leijon; Ake Lundkvist; Ali Mirazimi
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

6.  Nitric oxide and macrophage antiviral extrinsic activity.

Authors:  F Benencia; M C Courreges
Journal:  Immunology       Date:  1999-11       Impact factor: 7.397

7.  Coxsackievirus B3-induced myocarditis: perforin exacerbates disease, but plays no detectable role in virus clearance.

Authors:  J R Gebhard; C M Perry; S Harkins; T Lane; I Mena; V C Asensio; I L Campbell; J L Whitton
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

8.  Nitric oxide is elicited and inhibits viral replication in pigs infected with porcine respiratory coronavirus but not porcine reproductive and respiratory syndrome virus.

Authors:  Kwonil Jung; Ashita Gurnani; Gourapura J Renukaradhya; Linda J Saif
Journal:  Vet Immunol Immunopathol       Date:  2010-04-01       Impact factor: 2.046

Review 9.  Theiler's virus infection: a model for multiple sclerosis.

Authors:  Emilia L Oleszak; J Robert Chang; Herman Friedman; Christos D Katsetos; Chris D Platsoucas
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

10.  Progress in Anti-SARS Coronavirus Chemistry, Biology and Chemotherapy.

Authors:  Arun K Ghosh; Kai Xi; Michael E Johnson; Susan C Baker; Andrew D Mesecar
Journal:  Annu Rep Med Chem       Date:  2007-02-01       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.